These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


404 related items for PubMed ID: 14584417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T, Shimizu W, Inagaki M, Noda T, Miyoshi S, Ding WG, Zankov DP, Toyoda F, Matsuura H, Horie M, Sunagawa K.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):300-7. PubMed ID: 15653031
    [Abstract] [Full Text] [Related]

  • 4. Short QT syndrome: a review.
    Patel U, Pavri BB.
    Cardiol Rev; 2009 Jan 18; 17(6):300-3. PubMed ID: 19829181
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K, Dorian P.
    Europace; 2007 Sep 18; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
    Kecskeméti V.
    Neuropsychopharmacol Hung; 2004 Mar 18; 6(1):5-12. PubMed ID: 15125308
    [Abstract] [Full Text] [Related]

  • 10. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
    Fazekas T, Liszkai G.
    Orv Hetil; 2005 Mar 06; 146(10):451-60. PubMed ID: 15835343
    [Abstract] [Full Text] [Related]

  • 11. Short QT syndrome: pharmacological treatment.
    Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1494-9. PubMed ID: 15093889
    [Abstract] [Full Text] [Related]

  • 12. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E, Watson T, Lip GY.
    Europace; 2007 Sep 21; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [Abstract] [Full Text] [Related]

  • 13. [Short QT Syndromes].
    Schulze-Bahr E.
    Herz; 2006 Apr 21; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
    [Abstract] [Full Text] [Related]

  • 14. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W, Wichter T, Chen X, Hördt M, Willems S, Rotman B, Hindricks G, Kottkamp H, Borggrefe M, Breithardt G.
    Z Kardiol; 1994 Apr 21; 83 Suppl 5():75-85. PubMed ID: 7846949
    [Abstract] [Full Text] [Related]

  • 15. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun 21; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 16. TRIad: foundation for proarrhythmia (triangulation, reverse use dependence and instability).
    Hondeghem LM.
    Novartis Found Symp; 2005 Jun 21; 266():235-44; discussion 244-50. PubMed ID: 16050272
    [Abstract] [Full Text] [Related]

  • 17. [Sudden cardiac death and inherited repolarization disorders].
    Gościńska K, Sredniawa B, Pasyk S.
    Przegl Lek; 2002 Jun 21; 59(7):523-6. PubMed ID: 12516242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M, Coppa F, Cappucciati C, Brambilla P, d'Allio G, Caverzasi E, Barale F, De Ferrari GM.
    Curr Opin Investig Drugs; 2006 Mar 21; 7(3):256-63. PubMed ID: 16555686
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.